Cargando…
Emerging safety science : workshop summary /
The Institute of Medicine's Forum on Drug Discovery, Development, and Translation convened a workshop on Emerging Safety Science. A diverse group of experts from academia, industry, and government examined two broad approaches to improving drug safety: basic scientific approaches (genomics, met...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, DC :
National Academies Press,
©2008.
|
| Colección: | Online access: NCBI NCBI Bookshelf.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn608437399 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr bn||||||abp | ||
| 007 | cr bn||||||ada | ||
| 008 | 100422s2008 dcua ob 100 0 eng d | ||
| 010 | |z 2008299620 | ||
| 040 | |a OCLCE |b eng |e pn |c OCLCE |d OCLCQ |d CUY |d MMU |d NTE |d E7B |d IDEBK |d GPM |d CNCGM |d DKDLA |d NATAP |d OCLCQ |d OCLCO |d OCLCA |d OCLCQ |d FVL |d OCLCF |d OCLCQ |d NLGGC |d OCLCO |d YDXCP |d OCL |d OCLCO |d OCLCQ |d OCLCO |d N$T |d OCLCO |d OCLCQ |d OCLCO |d EBLCP |d OCLCO |d AZK |d LOA |d OCLCO |d OCLCA |d OCLCO |d VT2 |d OCLCQ |d COCUF |d CNNOR |d MOR |d LIP |d PIFBR |d OCLCQ |d MERER |d ZCU |d OCLCO |d CASUM |d OCLCQ |d MERUC |d OCLCQ |d OCLCO |d OCLCA |d BUF |d OCLCO |d GILDS |d NJR |d U3W |d KIJ |d OCLCO |d OCLCQ |d BRL |d OCLCO |d STF |d WRM |d OCLCQ |d NRAMU |d EZ9 |d ICG |d AU@ |d OCLCO |d WYU |d A6Q |d DKC |d OCLCQ |d OCLCO |d OCL |d OCLCO |d OCLCQ |d OCLCA |d OCLCQ |d OCL |d OCLCO |d OCLCA |d UKCRE |d UKBTH |d HS0 |d LVT |d OCLCO |d INARC |d OCLCQ |d OCLCO |d UKAHL |d SFB |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL |d OCLCA |d OCLCL | ||
| 019 | |a 228156992 |a 298787674 |a 475085512 |a 475275648 |a 607925597 |a 614507188 |a 656468966 |a 666919021 |a 722658614 |a 728037111 |a 923278378 |a 961528404 |a 962628233 |a 966100972 |a 971081406 |a 975243015 |a 975290976 |a 988490386 |a 990383164 |a 991952608 |a 999658078 |a 1006307409 |a 1021259508 |a 1028802273 |a 1037411636 |a 1037937539 |a 1038622409 |a 1045518680 |a 1047537059 |a 1048219140 |a 1055342235 |a 1058516050 |a 1064623935 |a 1081284567 |a 1083560665 |a 1097097480 |a 1119400719 |a 1119449421 |a 1119455464 |a 1120886770 |a 1153496949 |a 1156388370 |a 1159612416 |a 1204382258 |a 1204391584 |a 1227644141 |a 1228560762 |a 1229432672 |a 1244723226 |a 1249236438 |a 1275415398 |a 1276770961 |a 1289848184 |a 1290046723 | ||
| 020 | |a 9780309110136 |q (electronic bk.) | ||
| 020 | |a 0309110130 |q (electronic bk.) | ||
| 020 | |a 1281300233 | ||
| 020 | |a 9781281300232 | ||
| 020 | |a 9786611300234 | ||
| 020 | |a 6611300236 | ||
| 020 | |z 9780309110129 |q (pbk.) | ||
| 020 | |z 0309110122 |q (pbk.) | ||
| 020 | |a 9780309178174 |q (e-book) | ||
| 020 | |a 0309178177 | ||
| 024 | 8 | |a 9786611300234 | |
| 029 | 1 | |a AU@ |b 000051323271 | |
| 029 | 1 | |a DEBBG |b BV044108777 | |
| 029 | 1 | |a NZ1 |b 14239672 | |
| 029 | 1 | |a AU@ |b 000075782598 | |
| 029 | 1 | |a AU@ |b 000075839405 | |
| 029 | 1 | |a AU@ |b 000075862963 | |
| 029 | 1 | |a AU@ |b 000075879042 | |
| 035 | |a (OCoLC)608437399 |z (OCoLC)228156992 |z (OCoLC)298787674 |z (OCoLC)475085512 |z (OCoLC)475275648 |z (OCoLC)607925597 |z (OCoLC)614507188 |z (OCoLC)656468966 |z (OCoLC)666919021 |z (OCoLC)722658614 |z (OCoLC)728037111 |z (OCoLC)923278378 |z (OCoLC)961528404 |z (OCoLC)962628233 |z (OCoLC)966100972 |z (OCoLC)971081406 |z (OCoLC)975243015 |z (OCoLC)975290976 |z (OCoLC)988490386 |z (OCoLC)990383164 |z (OCoLC)991952608 |z (OCoLC)999658078 |z (OCoLC)1006307409 |z (OCoLC)1021259508 |z (OCoLC)1028802273 |z (OCoLC)1037411636 |z (OCoLC)1037937539 |z (OCoLC)1038622409 |z (OCoLC)1045518680 |z (OCoLC)1047537059 |z (OCoLC)1048219140 |z (OCoLC)1055342235 |z (OCoLC)1058516050 |z (OCoLC)1064623935 |z (OCoLC)1081284567 |z (OCoLC)1083560665 |z (OCoLC)1097097480 |z (OCoLC)1119400719 |z (OCoLC)1119449421 |z (OCoLC)1119455464 |z (OCoLC)1120886770 |z (OCoLC)1153496949 |z (OCoLC)1156388370 |z (OCoLC)1159612416 |z (OCoLC)1204382258 |z (OCoLC)1204391584 |z (OCoLC)1227644141 |z (OCoLC)1228560762 |z (OCoLC)1229432672 |z (OCoLC)1244723226 |z (OCoLC)1249236438 |z (OCoLC)1275415398 |z (OCoLC)1276770961 |z (OCoLC)1289848184 |z (OCoLC)1290046723 | ||
| 037 | |a 130023 |b MIL | ||
| 042 | |a dlr | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RM302.5 |b .E44 2008 | |
| 060 | 4 | |a 2008 I-822 | |
| 060 | 4 | |a QV 600 |b E53 2008 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615/.10289 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Emerging safety science : |b workshop summary / |c Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| 260 | |a Washington, DC : |b National Academies Press, |c ©2008. | ||
| 300 | |a 1 online resource (xvi, 134 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references (pages 115-116). | ||
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 520 | |a The Institute of Medicine's Forum on Drug Discovery, Development, and Translation convened a workshop on Emerging Safety Science. A diverse group of experts from academia, industry, and government examined two broad approaches to improving drug safety: basic scientific approaches (genomics, metabolomics, pharmacogenomics, cell-based signaling, and standard toxicology) to better identify safety issues during development; and innovative techniques for collecting and analyzing postmarket data to identify safety signals more rapidly than is possible with traditional methodologies. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Matter -- Reviewers -- Preface -- Contents -- Tables and Figures -- 1 Introduction -- 2 Investigative Toxicology: The State of the Art -- 3 Screening Technologies I: Human Cell�Based Approaches -- 4 Screening Technologies II: Toxicogenomics -- 5 Screening Technologies III: Metabolomics -- 6 Screening Technologies IV: Pharmacogenetics -- 7 Qualifying Biomarkers -- 8 Pharmacovigilance -- 9 Integration -- 10 The Future of Safety Science -- References -- Appendixes -- Appendix A: Workshop Agenda -- Appendix B: Speaker Biographies | |
| 546 | |a English. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Drugs |z United States |x Safety measures |v Congresses. | |
| 650 | 0 | |a Pharmaceutical biotechnology |z United States |v Congresses. | |
| 650 | 0 | |a Drugs |z United States |x Design |v Congresses. | |
| 650 | 0 | |a Drugs |x Side effects. | |
| 650 | 0 | |a Pharmacy. | |
| 650 | 0 | |a Drugs. | |
| 650 | 0 | |a Technology. | |
| 650 | 0 | |a Medical personnel. | |
| 650 | 0 | |a Drugs |x Side effects |x Reporting. | |
| 650 | 0 | |a Pharmacovigilance. | |
| 650 | 0 | |a Drug monitoring. | |
| 650 | 0 | |a Pharmaceutical technology. | |
| 650 | 0 | |a Human beings. | |
| 650 | 0 | 2 | |a Humans |
| 650 | 2 | |a Drug-Related Side Effects and Adverse Reactions | |
| 650 | 2 | |a Pharmacy | |
| 650 | 2 | |a Pharmaceutical Preparations | |
| 650 | 2 | |a Drug Evaluation, Preclinical | |
| 650 | 2 | |a Drug Evaluation | |
| 650 | 2 | |a Investigative Techniques | |
| 650 | 2 | |a Technology | |
| 650 | 2 | |a Technology, Industry, and Agriculture | |
| 650 | 2 | |a Health Occupations | |
| 650 | 2 | |a Analytical, Diagnostic and Therapeutic Techniques and Equipment | |
| 650 | 2 | |a Disciplines and Occupations | |
| 650 | 2 | |a Technology, Industry, Agriculture | |
| 650 | 1 | 2 | |a Drug Evaluation |x standards |
| 650 | 2 | 2 | |a Adverse Drug Reaction Reporting Systems |
| 650 | 2 | 2 | |a Biomarkers, Pharmacological |
| 650 | 2 | 2 | |a Drug Approval |x organization & administration |
| 650 | 2 | 2 | |a Drug Monitoring |x standards |
| 650 | 2 | 2 | |a Pharmacoepidemiology |
| 650 | 2 | 2 | |a Product Surveillance, Postmarketing |
| 650 | 2 | 2 | |a Technology, Pharmaceutical |
| 651 | 2 | |a United States | |
| 650 | 2 | |a Health Personnel | |
| 650 | 2 | |a Health Workforce. | |
| 650 | 2 | |a Drug Monitoring | |
| 650 | 2 | |a Pharmacovigilance | |
| 650 | 6 | |a Médicaments |z États-Unis |x Sécurité |x Mesures |v Congrès. | |
| 650 | 6 | |a Biotechnologie pharmaceutique |z États-Unis |v Congrès. | |
| 650 | 6 | |a Médicaments |z États-Unis |x Conception |v Congrès. | |
| 650 | 6 | |a Médicaments |x Effets secondaires. | |
| 650 | 6 | |a Pharmacie. | |
| 650 | 6 | |a Médicaments. | |
| 650 | 6 | |a Technologie. | |
| 650 | 6 | |a Personnel médical. | |
| 650 | 6 | |a Pharmacovigilance. | |
| 650 | 6 | |a Techniques pharmaceutiques. | |
| 650 | 6 | |a Êtres humains. | |
| 650 | 7 | |a pharmacies (health facilities ) |2 aat | |
| 650 | 7 | |a Homo sapiens (species) |2 aat | |
| 650 | 7 | |a pharmacy (discipline) |2 aat | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Technology |2 fast | |
| 650 | 7 | |a Pharmacy |2 fast | |
| 650 | 7 | |a Pharmacovigilance |2 fast | |
| 650 | 7 | |a Pharmaceutical technology |2 fast | |
| 650 | 7 | |a Medical personnel |2 fast | |
| 650 | 7 | |a Drugs |x Side effects |x Reporting |2 fast | |
| 650 | 7 | |a Drugs |x Side effects |2 fast | |
| 650 | 7 | |a Drugs |2 fast | |
| 650 | 7 | |a Drug monitoring |2 fast | |
| 650 | 7 | |a Drugs |x Design |2 fast | |
| 650 | 7 | |a Drugs |x Safety measures |2 fast | |
| 650 | 7 | |a Pharmaceutical biotechnology |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 655 | 2 | |a Congress | |
| 655 | 7 | |a proceedings (reports) |2 aat | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Robinson, Sally. | |
| 700 | 1 | |a Pool, Robert. | |
| 700 | 1 | |a Giffin, Robert B. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Drug Discovery, Development, and Translation. | |
| 758 | |i has work: |a Emerging safety science (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGy47tWKPr3RqXpg4cQbcX |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Emerging safety science. |d Washington, DC : National Academies Press, ©2008 |w (DLC) 2008299620 |w (OCoLC)226258893 |
| 830 | 0 | |a Online access: NCBI NCBI Bookshelf. | |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378332 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3378332 | ||
| 938 | |a ebrary |b EBRY |n ebr10225174 | ||
| 938 | |a EBSCOhost |b EBSC |n 991020 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 130023 | ||
| 938 | |a Internet Archive |b INAR |n emergingsafetysc0000unse | ||
| 938 | |a YBP Library Services |b YANK |n 6011461 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36616660 | ||
| 994 | |a 92 |b IZTAP | ||